Welcome to our dedicated page for Helo news (Ticker: HLOC), a resource for investors and traders seeking the latest updates and insights on Helo stock.
Helo Corp (HLOC) regularly issues news updates as a data-driven wellness technology company focused on AI-enabled wearables, biodata platforms and personalized nutrition devices. Its announcements describe ongoing development of the Helo AI™ platform, Life Sensing Technology® wearables and products such as BioStrip™, the BioSense health band™ and the NutraMatic™ personalized nutrition device.
Recent news has highlighted the planned market launch of the BioSense Watch, a thin wearable that Helo describes as its first device with an embedded personal air sensor designed to detect total volatile organic compounds (TVOC), estimate CO2 and monitor indoor and outdoor air quality near the wearer. The company has also reported on NutraMatic, a countertop device intended to provide AI-optimized, personalized combinations of nutrition supplements based on a user’s current biodata status.
Helo’s press releases also cover corporate developments and events, such as executive appointments, participation in investor conferences and presentations at gatherings like the Emerging Growth Conference and the Moneyshow®. In these forums, management has discussed the company’s refocused strategic direction, progress on Helo AI, NutraMatic production status and investigational studies designed to train its AI knowledge domain.
Investors and observers using the HLOC news page can review these updates to follow Helo’s product pipeline, technology initiatives, restructuring efforts and partnerships, including its blockchain-related agreement for de-identified data storage and potential user data monetization. The news feed provides a centralized view of Helo’s disclosed milestones and communications with the market.
Helo Corp. (OTC PINK:HLOC) announced its third quarter 2022 results, reporting revenues of $3.8 million, an 85% decline year-over-year. Despite this downturn, CEO Sean McVeigh expressed optimism for stronger fourth quarter revenues, driven by the recent launch of the BioSense Health Band. Gross margin improved by 1400 basis points to 82%, while net loss narrowed to $35,795. The company ended the quarter with $8.1 million in net assets and no debt, signaling a stable financial position amidst restructuring efforts.
Helo Corp (OTC PINK:HLOC) launched its new BioSense health band at an event in Okinawa, Japan, emphasizing user data ownership through its unique Proof-of-Sensing technology. This wearable device features advanced health monitoring capabilities, including blood oxygen levels, body temperature, and ECG analysis. CEO Sean McVeigh anticipates strong demand for BioSense, which will be available for shipment in November. Helo positions itself competitively against major brands like Apple and Samsung by focusing on data security and monetization for users.
Helo Corp. (OTC PINK:HLOC) announced new strategic initiatives aimed at reducing costs and refocusing its business model amid challenging market conditions. CEO Sean McVeigh noted that revenue has been negatively impacted by issues in the network marketing distribution channel. The company plans to discontinue its global network marketing operations, significantly reducing headcount, while expanding its portfolio with Helo-branded devices. Additionally, Helo aims to launch an affiliate-based customer acquisition model and contribute to a blockchain-based health data platform.
Helo Corp. (OTC PINK:HLOC) reported its Q2 2022 results with revenue of $3.5 million, a significant 83% decline year-over-year. The gross margin fell to 5%, down 5,000 basis points, due to rising material costs. Selling expenses increased to 45% of revenue, and general and administrative costs rose to 88.6%. The company faced a loss of $4.6 million for the quarter, with earnings per share at a loss of 5 cents, compared to a profit of 1 cent last year. Helo ended the quarter with $8.1 million in net assets and no debt.
Helo Corp (OTC PINK:HLOC), a developer in wearable technology, announced on June 10, 2022, the appointment of M&K CPAS, PLLC as its new independent auditor. This strategic change aims to facilitate Helo's transition from an alternative reporting company to a fully reporting company with the SEC. CEO Sean McVeigh highlighted this as a step towards their goal of listing on Nasdaq and enhancing shareholder value. The previous auditor, Wei, Wei & Co., LLP, had no disagreements on GAAP matters.
Helo Corp. (OTC PINK:HLOC) reported a 39% increase in revenue for Q1 2022, totaling $10.7 million. Gross margin decreased to 67.7%, down by 430 basis points, attributed to higher material costs. Selling expenses rose to 35% of revenue, while general and administrative costs grew to 27.7%. Overall profitability fell to 4.5%, with earnings per share down by four cents. The company ended the quarter with $25.9 million in total assets and no debt. Helo remains optimistic about navigating COVID-related challenges and expanding into new markets.
Helo Corp. (OTC PINK:HLOC) has announced the appointment of Clayton Jones as chief legal officer, effective March 31, 2022. Jones brings extensive legal expertise gained from his previous roles at Grōv Technologies and Nu Skin. CEO Seán McVeigh expressed confidence that Jones will enhance the executive team amid the company's growth in wearable technology and digital health. Helo Corp. continues to innovate by integrating blockchain and AI in its wellness solutions, empowering consumers with data control.
Helo Corp. (OTC:HLOC) announced its 2021 results, showcasing a record annual revenue of $64.7 million, representing a remarkable 276% growth.
Despite a 180 basis point decrease in gross margin to 68.7%, profitability improved by $10.2 million, and earnings per share stood at $0.12. The company ended the year with total assets of $27.8 million and no debt, indicating a strong balance sheet. Helo attributes its success to technological advancements and a shift in business model, while navigating challenges related to COVID-19.
Helo Corp. (OTC PINK:HLOC) has appointed Robert 'Bo' Short as CEO of its subsidiary, Vyvo Inc., to spearhead the U.S. launch and global expansion of its wellness technology products. With over 32 years in the direct selling industry, Short is recognized as a top leader and income earner, bringing valuable experience from two direct selling companies and leadership roles in various organizations. Helo Corp. focuses on digital health and creating a wellness-centered ecosystem through its advanced technology, including the Vyvo LifeWatches and data-driven platforms.
Helo Corp. (OTC PINK:HLOC) announces the appointment of Ryan C. Wood as the new chief financial officer, effective March 2, 2022. Wood has a strong background in finance, having previously served as vice president of global financial planning at Nu Skin Enterprises and holds degrees in finance and accountancy from Brigham Young University. CEO Seán McVeigh expressed confidence in Wood's ability to enhance the leadership team and drive growth. Helo Corp. focuses on digital health technology and wellness, utilizing its Life-Watch devices for data collection and user wellness.